Translational advances in pancreatic ductal adenocarcinoma therapy.

Hosein, Abdel Nasser; Dougan, Stephanie K; Aguirre, Andrew J; Maitra, Anirban

Hosein, Abdel Nasser; Dougan, Stephanie K; Aguirre, Andrew J; Maitra, Anirban.

Afiliación

Hosein AN; Division of Hematology & Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA. abdel.hosein@aah.org.
Dougan SK; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. abdel.hosein@aah.org.
Aguirre AJ; Sheikh Ahmed Bin Zayed Al Nahyan Center for Pancreatic Cancer Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA. abdel.hosein@aah.org.
Maitra A; Advocate Aurora Health, Vince Lombardi Cancer Clinic, Sheboygan, WI, USA. abdel.hosein@aah.org.

Nat Cancer ; 3(3): 272-286, 2022 03.

Article en En | MEDLINE | ID: mdl-35352061

Asunto(s)

Carcinoma Ductal Pancreático; Neoplasias Pancreáticas; Carcinoma Ductal Pancreático/genética; Humanos; Inmunoterapia; Terapia Molecular Dirigida; Neoplasias Pancreáticas/genética; Neoplasias Pancreáticas

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Límite: Humans Idioma: En Revista: Nat Cancer Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google